Tallantyre, Emma ORCID: https://orcid.org/0000-0002-3760-6634, Castle, Daniel, Karamura, Paul, Brice, Thomas, Joseph, Fady, Harding, Katharine and Robertson, Neil ORCID: https://orcid.org/0000-0002-5409-4909
2020.
Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort.
Multiple Sclerosis and Related Disorders
42
, 102056.
10.1016/j.msard.2020.102056
|
|
|
Castle, Daniel and Robertson, Neil P. ORCID: https://orcid.org/0000-0002-5409-4909
2019.
Treatment of progressive multifocal leukoencephalopathy.
Journal of Neurology
266
(10)
, pp. 2587-2589.
10.1007/s00415-019-09501-y
|
|
|
Castle, Dan and Robertson, Neil P. ORCID: https://orcid.org/0000-0002-5409-4909
2019.
Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
Journal of Neurology
266
(9)
, pp. 2338-2340.
10.1007/s00415-019-09485-9
|
|
|
Castle, Daniel, Wynford-Thomas, Ray, Loveless, Sam ORCID: https://orcid.org/0000-0002-5124-4115, Bentley, Emily, Howell, Owain W and Tallantyre, Emma C ORCID: https://orcid.org/0000-0002-3760-6634
2019.
Using biomarkers to predict clinical outcomes in multiple sclerosis.
Practical Neurology
19
(4)
, pp. 342-349.
10.1136/practneurol-2018-002000
|
|
|



Up a level